Table 2 Clinician-reported Patient Clinical Characteristics
From: The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis
Characteristic | Total (N = 25) | IG (N = 15) | DG (N = 10) |
|---|---|---|---|
Time in clinician’s practice (years) | |||
 Mean (SD) | 2.7 (3.7) | 0.9 (1.2) | 5.3 (4.5) |
 Range (Min, Max) | (0.1, 13.6) | (0.1, 4.2) | (0.5, 13.6) |
Duration of diagnosis (years) | |||
 Mean (SD) | 1.7 (1.8) | 1.7 (2.0) | 1.8 (1.6) |
 Range (Min, Max) | (0.2, 7.0) | (0.2, 7.0) | (0.4, 4.8) |
Current medications for gastroparesis, n (%)a | |||
 Gastric antisecretory agent | 11 (44.0%) | 7 (46.7%) | 4 (40.0%) |
 Prokinetic agent | 9 (36.0%) | 6 (40.0%) | 3 (30.0%) |
 Antiemetic agent | 9 (36.0%) | 7 (46.7%) | 2 (20.0%) |
 Diabetes medical treatment | 7 (28.0%) | 0 (0.0%) | 7 (70.0%) |
 Pain medications | 5 (20.0%) | 5 (33.3%) | 0 (0.0%) |
 Psychotropic agent | 4 (16.0%) | 3 (20.0%) | 1 (10.0%) |
 Gastric electric stimulation (pacemaker) | 1 (4.0%) | 0 (0.0%) | 1 (10.0%) |
 Otherb | 4 (16.0%) | 4 (26.7%) | 0 (0.0%) |
Prior GI specific surgeries, n (%) | |||
 Gastric electric stimulation (GES) | 1 (4.0%) | 0 (0.0%) | 1 (10.0%) |
 Otherc | 3 (12.0%) | 2 (13.3%) | 1 (10.0%) |
 None | 21 (84.0%) | 13 (86.7%) | 8 (80.0%) |
Time since most recent upper endoscopy (years) | |||
 Mean (SD) | 1.2 (1.5) | 1.2 (1.6) | 1.2 (1.2) |
 Range (Min, Max) | (0.0, 5.9) | (0.1, 5.9) | (0.0, 3.3) |
Physician rating of gastroparesis severity, n (%) | |||
 None | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
 Very mild | 3 (12.0%) | 1 (6.7%) | 2 (20.0%) |
 Mild | 10 (40.0%) | 4 (26.7%) | 6 (60.0%) |
 Moderate | 9 (36.0%) | 7 (46.7%) | 2 (20.0%) |
 Severe | 3 (12.0%) | 3 (20.0%) | 0 (0.0%) |
 Very severe | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Comorbid conditions, n (%)a | |||
 Obesity | 8 (32.0%) | 4 (26.7%) | 4 (40.0%) |
 Other gastrointestinal disorder (other than gastroparesis)d | 7 (28.0%) | 4 (26.7%) | 3 (30.0%) |
 Mood disorder or mental health condition | 4 (16.0%) | 3 (20.0%) | 1 (10.0%) |
 Insomnia/sleep problems | 4 (16.0%) | 4 (26.7%) | 0 (0.0%) |
 Respiratory condition | 4 (16.0%) | 3 (20.0%) | 1 (10.0%) |
 Cardiovascular condition | 3 (12.0%) | 1 (6.7%) | 2 (20.0%) |
 Dyslipedemia/hyperlipidemia | 3 (12.0%) | 0 (0.0%) | 3 (30.0%) |
 Neurological condition | 1 (4.0%) | 0 (0.0%) | 1 (10.0%) |
 Otherd | 4 (16.0%) | 3 (20.0%) | 1 (10.0%) |
 None | 3 (12.0%) | 2 (13.3%) | 1 (10.0%) |